Paragon Bioscience is a biotechnology incubator and an investment organization which was established with a significant purpose of helping individuals with illness that lack a specific therapy. Jeff Aronin is the Chief Executive Officer of Paragon Bioscience. Mr. Jeff is known for his generous heart for helping those suffering from rare diseases. The biotechnology group has been using advanced research methods to discover new innovative approaches for treatment and medication. Ever since the foundation of the medical research firm they have been using new treatment methods which exceed the already existing therapies in the pharmaceutical sector. Despite the groundbreaking techniques for treatment studied and used in the medical industry, Jeff Aronin wants to make a difference in the industry by taking the biotechnology to higher levels.
Through Paragon Bioscience, Mr. Aronin has been using his innovation and experience to heighten medical conceptualization for treating patients with rare diseases. Jeff believes that one needs to go beyond the current idea to treat conditions. Paragon Bioscience work together with a team of experienced researchers and who are passionate about studying new treatment methods. Paragon has also been working with some companies, and each company has researchers who are working on innovating treatment for a specified illness. Each of the organization is led by different leaders although they are part of the Paragon Bioscience portfolio. Paragon Bioscience is a brand name in the biotechnology industry and through Jeff’s Aronin leadership and his team of researchers they have developed 14 drugs which have been approved by the United States Food and Drugs Administration (FDA).
Jeff Aronin is passionate about the biotechnology sector, and even though his organization prides herself for being among the top companies in the medical industry, Jeff is not satisfied by the Food and Drugs Administration approval, and he is committed to providing financial assistance to medical researchers who are dedicated. Mr. Aronin has been offering researchers with the needed funds in their studies. Aronin’s research team is committed to finding treatment for rare blood disorder to other illnesses which are related to the nervous system, and they have been working effortlessly to find ways in which patients can live longer and healthier. For over 20 years Jeff Aronin has been working in the biotechnology industry.